NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat Central Nervous System disorders. NeuroVentures serves as the General Partner to the NeuroVentures Fund, LP, a Delaware limited partnership with committed capital in excess of $15 million.
2008-11-19-1121 SELECT * FROM `master` WHERE CompanyID='7927' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30